Euclidean Capital LLC Q4 2024 Filing
Filed February 14, 2025
Portfolio Value
$736.7B
Holdings
11
Report Date
Q4 2024
Filing Type
13F-HR
All Holdings (11 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | SPYSPDR S&P 500 ETF TR | 896,254 | $525.3B | 71.30% | |
| 2 | INDAISHARES TR | 2,425,144 | $127.7B | 17.33% | |
| 3 | VEUVANGUARD INTL EQUITY INDEX F | 1,013,434 | $58.2B | 7.90% | |
| 4 | ORICORIC PHARMACEUTICALS INC | 989,410 | $8.0B | 1.08% | |
| 5 | FHTXFOGHORN THERAPEUTICS INC | 1,573,761 | $7.4B | 1.01% | |
| 6 | PMVPPMV PHARMACEUTICALS INC | 2,627,643 | $4.0B | 0.54% | |
| 7 | ALECALECTOR INC | 1,307,858 | $2.5B | 0.34% | |
| 8 | TNYATENAYA THERAPEUTICS INC | 1,015,705 | $1.5B | 0.20% | |
| 9 | SRZNSURROZEN INC | 87,696 | $1.3B | 0.17% | |
| 10 | RAPTEURRAPT THERAPEUTICS INC | 657,899 | $1.0B | 0.14% | |
| 11 | SRZNWSURROZEN INC | 170,833 | $3.7M | 0.00% |